Cargando…
Lidocaine transdermal patches reduced pain intensity in neuropathic cancer patients already receiving opioid treatment
BACKGROUND: Limited efficacy has been observed when using opioids to treat neuropathic pain. Lidocaine patches reduce neuropathic pain in postherpetic neuralgia, but their benefits for cancer-related neuropathic pain remain unclear. This study aimed to investigate a treatment for cancer-related neur...
Autores principales: | Tsai, Jui-Hung, Liu, I-Ting, Su, Pei-Fang, Huang, Ying-Tzu, Chiu, Ge-Lin, Chen, Yu-Yeh, Lai, Wei-Shu, Lin, Peng-Chan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9824981/ https://www.ncbi.nlm.nih.gov/pubmed/36609269 http://dx.doi.org/10.1186/s12904-023-01126-3 |
Ejemplares similares
-
Lidocaine 5% Patch in Localized Neuropathic Pain
por: Nair, Abhijit S, et al.
Publicado: (2019) -
Preliminary Study for the Preparation of Transmucosal or Transdermal Patches with Acyclovir and Lidocaine
por: Marioane, Cristina-Adela, et al.
Publicado: (2021) -
Transdermal Lidocaine and Ketamine for Neuropathic Pain: A Study of Effectiveness and Tolerability
por: Tam, Emily, et al.
Publicado: (2012) -
Treatment of Neuropathic Pain with the Capsaicin 8% Patch: Is Pretreatment with Lidocaine Necessary?
por: Kern, Kai-Uwe, et al.
Publicado: (2014) -
Mechanistic Study of Release Characteristics of Two Active Ingredients in Transdermal Patch Containing Lidocaine−Flurbiprofen Ionic Liquid
por: Yang, Degong, et al.
Publicado: (2022)